Recurrent homozygous damaging mutation in TMX2, encoding a protein disulfide isomerase, in four families with microlissencephaly. Issue 4 (5th October 2019)
- Record Type:
- Journal Article
- Title:
- Recurrent homozygous damaging mutation in TMX2, encoding a protein disulfide isomerase, in four families with microlissencephaly. Issue 4 (5th October 2019)
- Main Title:
- Recurrent homozygous damaging mutation in TMX2, encoding a protein disulfide isomerase, in four families with microlissencephaly
- Authors:
- Ghosh, Shereen Georges
Wang, Lu
Breuss, Martin W
Green, Joshua D
Stanley, Valentina
Yang, Xiaoxu
Ross, Danica
Traynor, Bryan J
Alhashem, Amal M
Azam, Matloob
Selim, Laila
Bastaki, Laila
Elbastawisy, Hanan I
Temtamy, Samia
Zaki, Maha
Gleeson, Joseph G - Abstract:
- Abstract : Background: Protein disulfide isomerase (PDI) proteins are part of the thioredoxin protein superfamily. PDIs are involved in the formation and rearrangement of disulfide bonds between cysteine residues during protein folding in the endoplasmic reticulum and are implicated in stress response pathways. Methods: Eight children from four consanguineous families residing in distinct geographies within the Middle East and Central Asia were recruited for study. All probands showed structurally similar microcephaly with lissencephaly (microlissencephaly) brain malformations. DNA samples from each family underwent whole exome sequencing, assessment for repeat expansions and confirmatory segregation analysis. Results: An identical homozygous variant in TMX2 (c.500G>A), encoding thioredoxin-related transmembrane protein 2, segregated with disease in all four families. This variant changed the last coding base of exon 6, and impacted mRNA stability. All patients presented with microlissencephaly, global developmental delay, intellectual disability and epilepsy. While TMX2 is an activator of cellular C9ORF72 repeat expansion toxicity, patients showed no evidence of C9ORF72 repeat expansions. Conclusion: The TMX2 c.500G>A allele associates with recessive microlissencephaly, and patients show no evidence of C9ORF72 expansions. TMX2 is the first PDI implicated in a recessive disease, suggesting a protein isomerisation defect in microlissencephaly.
- Is Part Of:
- Journal of medical genetics. Volume 57:Issue 4(2020)
- Journal:
- Journal of medical genetics
- Issue:
- Volume 57:Issue 4(2020)
- Issue Display:
- Volume 57, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 57
- Issue:
- 4
- Issue Sort Value:
- 2020-0057-0004-0000
- Page Start:
- 274
- Page End:
- 282
- Publication Date:
- 2019-10-05
- Subjects:
- TMX2 -- thioredoxin -- ER stress -- microlissencephaly -- protein disulfide isomerase
Medical genetics -- Periodicals
616.042 - Journal URLs:
- http://jmg.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/jmedgenet-2019-106409 ↗
- Languages:
- English
- ISSNs:
- 1468-6244
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19672.xml